Introduction Replicated evidence indicates that ketamine and esketamine reduces measures of suicidality in persons with treatment resistant depression (TRD). It remains uncertain whether susceptible individuals may experience worsening of pre-existing suicidality with either agent.
No takes yet. Share an insight, caveat, or question.
McIntyre et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: